Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight

BACKGROUND: Patient characteristics and disease progression may affect response to pharmacologic intervention in bipolar I disorder. Asenapine is approved for acute treatment of manic/mixed episodes of bipolar I disorder in patients 10–17 years old. Post hoc analyses assessed asenapine efficacy in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Findling, Robert L, Earley, Willie, Suppes, Trisha, Patel, Mehul, Wu, Xiao, Chang, Cheng-Tao, McIntyre, Roger S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080865/
https://www.ncbi.nlm.nih.gov/pubmed/30122926
http://dx.doi.org/10.2147/NDT.S165743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080865/
https://www.ncbi.nlm.nih.gov/pubmed/30122926
http://dx.doi.org/10.2147/NDT.S165743

Ejemplares similares